Neurotoxicity preventive effect of oxaliplatin with lipoic acid plus sodium potassium magnesium calcium and glucose injection

A total of 218 patients on chemotherapeutic regimens containing oxaliplatin were randomly divided into experimental (n=120) and control (n=98) groups. The experimental group received an intravenous infusion of lipoic acid plus sodium potassium magnesium calcium and glucose injection. The control group had only normal saline. Overall incidence of neurotoxicity and toxicity grade of peripheral nerve were observed after 4, 8 and 12 cycles. Those with neurotoxic symptoms were followed up for 1 year. No significantly statistical difference existed in the incidence of peripheral neurotoxicity after 4, 8 cycles (P>0.05). After 12 cycles, 31 patients in the experimental group had an onset of neurotoxicity of grade 3 (n=8, 6.7%) & grade 4 (n=0) versus 21 cases of grade 3 (n=21, 21.4%) and grade 4 (n=5, 5.1%) in the control group. Statistically significant differences existed between grades 3 and 4 neurotoxicity (P<0.05). After 1 year of follow-up, the incidence of grade 1 of neurotoxicity was 2.5% (n=3) in the experimental group versus 23.7% (n=9) in the control group. And the inter-group difference was statistically significant (P<0.05). Lipoic acid plus sodium potassium magnesium, calcium and glucose injection can effectively prevent the occurrences of acute and chronic peripheral neurotoxicity associated with oxaliplatin. Key words: Neurotoxicity; Oxaliplatin